Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2021

06.03.2020 | Original Article

A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation

verfasst von: Xueyun Zhang, Yue Ying, Pu Zhou, Xiaoqin Liu, Ruidong Li, Yifeng Tao, Minhui Dong, Beidi Zhu, Xun Qi, Qianqian Wang, Xiaofei Zhang, Jingwen Wu, Jianming Zheng, Weifeng Zhao, Wenhong Zhang, Zhengxin Wang, Jiming Zhang, Yuxian Huang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a dynamic but reversible disease.

Aim

We aimed to clarify whether the change in Chinese Group on the Study of Severe Hepatitis B-ACLF (COSSH-ACLF) grade in HBV-ACLF patients can be used to predict prognosis, and to explore the appropriate conditions for performing urgent liver transplantation.

Methods

We assessed the COSSH-ACLF grades of HBV-ACLF patients at different time points from June 2013 to May 2019 at Huashan Hospital in Shanghai, China, and analyzed the relationship between the change in grade and patient prognosis.

Results

A total of 207 HBV-ACLF patients were enrolled, of which 79 underwent urgent liver transplantation. Their COSSH-ACLF grades were calculated at diagnosis, 3–7 days after diagnosis, and on the final day. Most of the final ACLF grades were consistent with their corresponding grades at days 3–7 after diagnosis (62.5%), while only 44.5% were in accordance with the initial grades at diagnosis. In patients who had a poor prognosis (initial ACLF-3 and ACLF-2 or -3 at days 3–7), the 28-day survival rate was 93.3% in those who underwent transplantation and 6.8% in those who did not (P < 0.0001). However, in patients who had a good prognosis (ACLF-0 or ACLF-1 at days 3–7), the 28-day survival rate was 100% in transplanted patients and 91.5% in non-transplanted patients (P = 0.236).

Conclusions

Reevaluation of the COSSH-ACLF grade 3–7 days after diagnosis could potentially show an indication for urgent liver transplantation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bernal W, Jalan R, Quaglia A, et al. Acute-on-chronic liver failure. Lancet. 2015;386:1576–1587.CrossRef Bernal W, Jalan R, Quaglia A, et al. Acute-on-chronic liver failure. Lancet. 2015;386:1576–1587.CrossRef
2.
Zurück zum Zitat Sarin SK, Kedarisetty CK, Abbas Z, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) 2014. Hepatol Int. 2014;8:453–471.CrossRef Sarin SK, Kedarisetty CK, Abbas Z, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) 2014. Hepatol Int. 2014;8:453–471.CrossRef
3.
Zurück zum Zitat Moreau R, Jalan R, Gines P, et al. Acute on chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437.CrossRef Moreau R, Jalan R, Gines P, et al. Acute on chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437.CrossRef
4.
Zurück zum Zitat Gustot T, Fernandez J, Garcia E, et al. Clinical course of acute-on chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62:243–252.CrossRef Gustot T, Fernandez J, Garcia E, et al. Clinical course of acute-on chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62:243–252.CrossRef
5.
Zurück zum Zitat West J, Card TR, Aithal GP, Fleming KM. Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study. Aliment Pharmacol Ther. 2017;45:983–990.CrossRef West J, Card TR, Aithal GP, Fleming KM. Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study. Aliment Pharmacol Ther. 2017;45:983–990.CrossRef
6.
Zurück zum Zitat Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P. Alcoholic liver disease confers a worse prognosis than HCV infection and nonalcoholic fatty liver disease among patients with cirrhosis: an observational study. PLoS ONE. 2017;12:e0186715.CrossRef Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P. Alcoholic liver disease confers a worse prognosis than HCV infection and nonalcoholic fatty liver disease among patients with cirrhosis: an observational study. PLoS ONE. 2017;12:e0186715.CrossRef
7.
Zurück zum Zitat Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut.. 2018;67:2181–2191.CrossRef Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut.. 2018;67:2181–2191.CrossRef
8.
Zurück zum Zitat Hernaez R, Solà E, Moreau R, Gines P. Acute-on-chronic liver failure: an update. Gut. 2017;66:541–553.CrossRef Hernaez R, Solà E, Moreau R, Gines P. Acute-on-chronic liver failure: an update. Gut. 2017;66:541–553.CrossRef
9.
Zurück zum Zitat European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433–485.CrossRef European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433–485.CrossRef
10.
Zurück zum Zitat Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology.. 2007;45:797–805.CrossRef Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology.. 2007;45:797–805.CrossRef
11.
Zurück zum Zitat Massie AB, Chow EK, Wickliffe CE, et al. Early changes in liver distribution following implementation of Share 35. Am J Transplant. 2015;15:659–667.CrossRef Massie AB, Chow EK, Wickliffe CE, et al. Early changes in liver distribution following implementation of Share 35. Am J Transplant. 2015;15:659–667.CrossRef
12.
Zurück zum Zitat Brooks JT, Koizumi N, Neglia E, et al. Improved retransplant outcomes: early evidence of the share35 impact. HPB (Oxford). 2018;20:649–657.CrossRef Brooks JT, Koizumi N, Neglia E, et al. Improved retransplant outcomes: early evidence of the share35 impact. HPB (Oxford). 2018;20:649–657.CrossRef
13.
Zurück zum Zitat Goel A, Kim WR, Pyke J, et al. Liver simulated allocation modeling: were the predictions accurate for share 35? Transplantation. 2018;102:769–774.CrossRef Goel A, Kim WR, Pyke J, et al. Liver simulated allocation modeling: were the predictions accurate for share 35? Transplantation. 2018;102:769–774.CrossRef
14.
Zurück zum Zitat Murken DR, Peng AW, Aufhauser DD Jr, Abt PL, Goldberg DS, Levine MH. Same policy, different impact: center-level effects of share 35 liver allocation. Liver Transpl. 2017;23:741–750.CrossRef Murken DR, Peng AW, Aufhauser DD Jr, Abt PL, Goldberg DS, Levine MH. Same policy, different impact: center-level effects of share 35 liver allocation. Liver Transpl. 2017;23:741–750.CrossRef
15.
Zurück zum Zitat Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol. 2010;7:659–668.CrossRef Cholongitas E, Germani G, Burroughs AK. Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol. 2010;7:659–668.CrossRef
16.
Zurück zum Zitat Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54:1297–1306.CrossRef Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54:1297–1306.CrossRef
17.
Zurück zum Zitat Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–266.CrossRef Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–266.CrossRef
18.
Zurück zum Zitat Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–832.CrossRef Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–832.CrossRef
19.
Zurück zum Zitat Arroyo V, Jiménez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol. 2000;32:157–170.CrossRef Arroyo V, Jiménez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol. 2000;32:157–170.CrossRef
20.
Zurück zum Zitat Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660.CrossRef Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652–1660.CrossRef
21.
Zurück zum Zitat Abad-Lacruz A, Cabré E, González-Huix F, et al. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child–Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol. 1993;88:382–387.PubMed Abad-Lacruz A, Cabré E, González-Huix F, et al. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child–Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol. 1993;88:382–387.PubMed
22.
Zurück zum Zitat Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038–1047.CrossRef Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61:1038–1047.CrossRef
23.
Zurück zum Zitat Jalan R, Yurdaydin C, Bajaj JS, et al. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology. 2014;147:4–10.CrossRef Jalan R, Yurdaydin C, Bajaj JS, et al. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology. 2014;147:4–10.CrossRef
24.
Zurück zum Zitat Asrani SK, Simonetto DA, Kamath PS. Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol. 2015;13:2128–2139.CrossRef Asrani SK, Simonetto DA, Kamath PS. Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol. 2015;13:2128–2139.CrossRef
25.
Zurück zum Zitat Choudhury A, Jindal A, Maiwall R, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017;11:461–471.CrossRef Choudhury A, Jindal A, Maiwall R, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017;11:461–471.CrossRef
26.
Zurück zum Zitat Shalimar S, Kumar D, Vairaja PK, et al. Acute on chronic liver failure because of acute hepatic insults: etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol. 2016;31:856–864.CrossRef Shalimar S, Kumar D, Vairaja PK, et al. Acute on chronic liver failure because of acute hepatic insults: etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol. 2016;31:856–864.CrossRef
27.
Zurück zum Zitat Bajaj JS, Oleary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures. Hepatology. 2014;60:250–256.CrossRef Bajaj JS, Oleary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures. Hepatology. 2014;60:250–256.CrossRef
28.
Zurück zum Zitat Fernández J, Acevedo J, Wiest R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67:1870–1880.CrossRef Fernández J, Acevedo J, Wiest R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67:1870–1880.CrossRef
29.
Zurück zum Zitat Hassanein TI, Tofteng F, Brown RS Jr, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007;46:1853–1862.CrossRef Hassanein TI, Tofteng F, Brown RS Jr, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007;46:1853–1862.CrossRef
30.
Zurück zum Zitat Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:782–789.CrossRef Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:782–789.CrossRef
31.
Zurück zum Zitat Banares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57:1153–1162.CrossRef Banares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57:1153–1162.CrossRef
32.
Zurück zum Zitat Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care. 2006;10:R108.CrossRef Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care. 2006;10:R108.CrossRef
33.
Zurück zum Zitat Bañares R, Ibáñez-Samaniego L, Torner JM, et al. Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity. Therap Adv Gastroenterol. 2019;12:1756284819879565.CrossRef Bañares R, Ibáñez-Samaniego L, Torner JM, et al. Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity. Therap Adv Gastroenterol. 2019;12:1756284819879565.CrossRef
Metadaten
Titel
A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation
verfasst von
Xueyun Zhang
Yue Ying
Pu Zhou
Xiaoqin Liu
Ruidong Li
Yifeng Tao
Minhui Dong
Beidi Zhu
Xun Qi
Qianqian Wang
Xiaofei Zhang
Jingwen Wu
Jianming Zheng
Weifeng Zhao
Wenhong Zhang
Zhengxin Wang
Jiming Zhang
Yuxian Huang
Publikationsdatum
06.03.2020
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06149-x

Weitere Artikel der Ausgabe 1/2021

Digestive Diseases and Sciences 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.